These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 20547927)
21. Serotonin transporter is not required for the development of severe pulmonary hypertension in the Sugen hypoxia rat model. de Raaf MA; Kroeze Y; Middelman A; de Man FS; de Jong H; Vonk-Noordegraaf A; de Korte C; Voelkel NF; Homberg J; Bogaard HJ Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(10):L1164-73. PubMed ID: 26386116 [TBL] [Abstract][Full Text] [Related]
23. The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension. Sakao S; Tatsumi K Respiration; 2011; 81(3):253-61. PubMed ID: 21116108 [TBL] [Abstract][Full Text] [Related]
24. S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Greenway S; van Suylen RJ; Du Marchie Sarvaas G; Kwan E; Ambartsumian N; Lukanidin E; Rabinovitch M Am J Pathol; 2004 Jan; 164(1):253-62. PubMed ID: 14695338 [TBL] [Abstract][Full Text] [Related]
25. Endothelial fate mapping in mice with pulmonary hypertension. Qiao L; Nishimura T; Shi L; Sessions D; Thrasher A; Trudell JR; Berry GJ; Pearl RG; Kao PN Circulation; 2014 Feb; 129(6):692-703. PubMed ID: 24201301 [TBL] [Abstract][Full Text] [Related]
26. Increased expression of hypoxia-inducible factor-1α in proliferating neointimal lesions in a rat model of pulmonary arterial hypertension. Yan J; Shen Y; Wang Y; Li BB Am J Med Sci; 2013 Feb; 345(2):121-8. PubMed ID: 22627259 [TBL] [Abstract][Full Text] [Related]
27. Novel dual endothelin receptor antagonist macitentan reverses severe pulmonary arterial hypertension in rats. Kunita-Takanezawa M; Abe K; Hirooka Y; Kuwabara Y; Hirano K; Oka M; Sunagawa K J Cardiovasc Pharmacol; 2014 Nov; 64(5):473-80. PubMed ID: 25084082 [TBL] [Abstract][Full Text] [Related]
28. Electron microscopy of hypertensive pulmonary vascular disease. Heath D; Smith P Br J Dis Chest; 1983 Jan; 77(1):1-13. PubMed ID: 6860554 [TBL] [Abstract][Full Text] [Related]
29. Different distribution of plexiform lesions in primary and secondary pulmonary hypertension. Jamison BM; Michel RP Hum Pathol; 1995 Sep; 26(9):987-93. PubMed ID: 7672799 [TBL] [Abstract][Full Text] [Related]
30. Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension? Voelkel NF; Bogaard HJ; Al Husseini A; Farkas L; Gomez-Arroyo J; Natarajan R Antioxid Redox Signal; 2013 May; 18(14):1810-7. PubMed ID: 22870869 [TBL] [Abstract][Full Text] [Related]
31. Involvement of endothelial progenitor cells in the formation of plexiform lesions in broiler chickens: possible role of local immune/inflammatory response. Tan X; Juan FG; Shah AQ J Zhejiang Univ Sci B; 2017 Jan.; 18(1):59-69. PubMed ID: 28070997 [TBL] [Abstract][Full Text] [Related]
32. Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen-hypoxia rat model by cardiac magnetic resonance imaging. Jayasekera G; Wilson KS; Buist H; Woodward R; Uckan A; Hughes C; Nilsen M; Church AC; Johnson MK; Gallagher L; Mullin J; MacLean MR; Holmes WM; Peacock AJ; Welsh DJ Pulm Circ; 2020; 10(1):2045894019897513. PubMed ID: 32095230 [TBL] [Abstract][Full Text] [Related]
33. CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension. Ohta-Ogo K; Hao H; Ishibashi-Ueda H; Hirota S; Nakamura K; Ohe T; Ito H Pathol Int; 2012 Apr; 62(4):219-25. PubMed ID: 22449225 [TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Cool CD; Kennedy D; Voelkel NF; Tuder RM Hum Pathol; 1997 Apr; 28(4):434-42. PubMed ID: 9104943 [TBL] [Abstract][Full Text] [Related]
35. Pulmonary arteriopathy and idiopathic pulmonary arterial hypertension in six dogs. Zabka TS; Campbell FE; Wilson DW Vet Pathol; 2006 Jul; 43(4):510-22. PubMed ID: 16846993 [TBL] [Abstract][Full Text] [Related]
36. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Stenmark KR; Meyrick B; Galie N; Mooi WJ; McMurtry IF Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1013-32. PubMed ID: 19748998 [TBL] [Abstract][Full Text] [Related]
37. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Sahara M; Sata M; Morita T; Nakamura K; Hirata Y; Nagai R Circulation; 2007 Jan; 115(4):509-17. PubMed ID: 17242277 [TBL] [Abstract][Full Text] [Related]
38. Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats. Schwenke DO; Tokudome T; Shirai M; Hosoda H; Horio T; Kishimoto I; Kangawa K Endocrinology; 2008 Jan; 149(1):237-44. PubMed ID: 17916633 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance. Jujo T; Sakao S; Ishibashi-Ueda H; Ishida K; Naito A; Sugiura T; Shigeta A; Tanabe N; Masuda M; Tatsumi K PLoS One; 2015; 10(8):e0133167. PubMed ID: 26252755 [TBL] [Abstract][Full Text] [Related]
40. Expression and role of factor inhibiting hypoxia-inducible factor-1 in pulmonary arteries of rat with hypoxia-induced hypertension. Fu D; Dai A; Hu R; Chen Y; Zhu L Acta Biochim Biophys Sin (Shanghai); 2008 Oct; 40(10):883-92. PubMed ID: 18850054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]